尿道抗微生物与胆酸平衡和儿童肥胖症有关
Yuanping Wang1, Pu Liu2, Yi Wang1
1Key Laboratory of Public Health Safety of Ministry of Education/School of Public Health, Fudan University, Shanghai 200032, China.
Ecotoxicology and environmental safety
|December 16, 2025
概括
儿童接触抗菌剂与胆酸平衡的变化以及肥胖的风险更高有关. 胆酸干扰可能部分解释了这种联系,突出了潜在的公共卫生问题.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 环境健康 环境健康
- 代谢学 代谢学 代谢学
背景情况:
- 关于抗微生物药物暴露对儿童胆酸稳态和脂肪生成的影响的研究有限.
- 抗微生物药物可能会影响与体重调节相关的代谢途径.
研究的目的:
- 在小儿群体中调查抗微生物暴露,胆酸概况和脂肪生成标志物之间的关联.
- 探索胆酸失调在抗微生物药物和儿童肥胖之间的关系中的潜在调解作用.
主要方法:
- 上海的一组1134名儿童接受了尿路抗菌剂和胆酸测量.
- 脂肪生成指标包括BMI,腰围和超重/肥胖的分类.
- 胆酸比率被计算出来以评估微生物的转化.
主要成果:
- 抗菌剂暴露与特定胆汁酸 (例如,LCA,GCDCA) 和胆汁酸比率的水平变化相关.
- 尿路抗微生物药物与BMI,腰围和中心肥胖有积极的关联.
- 抗微生物度较高的儿童表现出中心超重/肥胖的几率增加.
结论:
- 暴露于抗微生物药物可能会破坏胆酸平衡,可能会增加儿童肥胖风险.
- 胆酸失调似乎是抗微生物药物暴露与儿科肥胖之间联系的部分调解者.
相关概念视频
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
339
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
339
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
230
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
230
Hepatic Drug Excretion: Influencing Factors
504
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
504
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174


